Published March 2016 | Version v1
Journal article

Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT

  • 1. Erasmus MC, Radiology, Rotterdam (Netherlands)
  • 2. Sophia Children's Hospital, Pediatric Pulmonology Erasmus MC, Rotterdam (Netherlands)
  • 3. General Hospital Ca' Foncello, Radiology Department, Treviso (Italy)
  • 4. University of Rome ''Sapienza'', Radiology, Rome (Italy)
  • 5. Erasmus MC, Epidemiology, Rotterdam (Netherlands)
  • 6. Ca' Foncello Hospital, Pediatrics, Treviso (Italy)
  • 7. University College London (UCL), Institute of Nuclear Medicine, London (United Kingdom)
  • 8. University of Rome Sapienza, Pediatrics, Rome (Italy)
  • 9. Azienda Ospedaliera di Verona, Verona CF Center, Verona (Italy)
  • 10. University of Padova, Department of Medicine-DIMED, Padova (Italy)

Description

To date, PROPELLER MRI, a breathing-motion-insensitive technique, has not been assessed for cystic fibrosis (CF) lung disease. We compared this technique to CT for assessing CF lung disease in children and adults. Thirty-eight stable CF patients (median 21 years, range 6-51 years, 22 female) underwent MRI and CT on the same day. Study protocol included respiratory-triggered PROPELLER MRI and volumetric CT end-inspiratory and -expiratory acquisitions. Two observers scored the images using the CF-MRI and CF-CT systems. Scores were compared with intra-class correlation coefficient (ICC) and Bland-Altman plots. The sensitivity and specificity of MRI versus CT were calculated. MRI sensitivity for detecting severe CF bronchiectasis was 0.33 (CI 0.09-0.57), while specificity was 100 % (CI 0.88-1). ICCs for bronchiectasis and trapped air were as follows: MRI-bronchiectasis (0.79); CT-bronchiectasis (0.85); MRI-trapped air (0.51); CT-trapped air (0.87). Bland-Altman plots showed an MRI tendency to overestimate the severity of bronchiectasis in mild CF disease and underestimate bronchiectasis in severe disease. Motion correction in PROPELLER MRI does not improve assessment of CF lung disease compared to CT. However, the good inter- and intra-observer agreement and the high specificity suggest that MRI might play a role in the short-term follow-up of CF lung disease (i.e. pulmonary exacerbations). (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-015-3850-9

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology
Journal Volume
26
Journal Issue
3
Journal Page Range
p. 780-787
ISSN
0938-7994
CODEN
EURAE3